CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%

5 hours ago 1

Top view of business office workstation with M&A letters or merger and acquisition

CARGO Therapeutics (NASDAQ:CRGX) has announced a definitive merger agreement to be acquired by Concentra Biosciences, LLC for $4.379 in cash per share of CARGO common stock, plus one non-transferable contingent value right.

A non-transferable contingent value right (CVR) allows the holder to

Recommended For You

More Trending News

Read Entire Article